References
- Kesisoglou F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631–644.
- Shukla D, Chakraborty S, Singh S, Mishra B. Lipid-based oral multiparticulate formulations – advantages, technological advances and industrial applications. Expert Opin Drug Deliv 2011;8:207–224.
- Liu H, Edgar KJ. Synthesis and characterization of neutral and anionic cellulosic amphiphiles. Carbohydr Polym 2014;113:480–489.
- Liu H, Ilevbare GA, Cherniawski BP, et al. Synthesis and structure–property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions. Carbohydr Polym 2014;100:116–125.
- Yu LX, Amidon GL, Polli JE, et al. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res 2002;19:921–925.
- Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011;420:1–10.
- Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–1075.
- Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007;59:617–630.
- Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
- Berge SM, Bighley LD, Monkhouse DC. Pharmaceutical salts. J Pharm Sci 1977;66:1–19.
- Fatouros D, Deen GR, Arleth L, et al. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm Res 2007;24:1844–1853.
- Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002;54:169–190.
- Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1–11.
- Mueller E, Kovarik J, van Bree J, et al. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 1994;11:301–304.
- Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm 1998;160:229–237.
- Park JH, Choi HK. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Arch Pharm Res 2015;38:1336–1344.
- Potta SG, Minemi S, Nukala RK, et al. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. J Biomed Nanotechnol 2010;6:634–640.
- Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–796.
- Rautio J, Kumpulainen H, Heimbach T, et al. Prodrugs: design and clinical applications. Nat Rev Drug Discov 2008;7:255–270.
- Saoji SD, Raut NA, Dhore PW, et al. Preparation and evaluation of phospholipid-based complex of standardized centella extract (SCE) for the enhanced delivery of phytoconstituents. AAPS J 2016;18:102–114.
- Khan J, Saraf S, Saraf S. Preparation and evaluation of luteolin-phospholipid complex as an effective drug delivery tool against GalN/LPS induced liver damage . Pharm Dev Technol 2016;21:475–486.
- Puntawee S, Theerasilp M, Reabroi S, et al. Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy. Pharm Dev Technol 2016;21:437–444.
- Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–1302.
- Karavas E, Georgarakis E, Sigalas MP, et al. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions. Eur J Pharm Biopharm 2007; 66:334–347.
- Bikiaris D, Papageorgiou GZ, Stergiou A, et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta 2005;439:58–67.
- Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B Biointerfaces 2010;76:170–178.
- Lea AP, Faulds D. Ritonavir. Drugs 1996;52:541–546. discussion 547–548.
- de Kruif CG. Casein micelle interactions. Int Dairy J 1999;9:183–188.
- Portnaya I, Ben-Shoshan E, Cogan U, et al. Self-assembly of bovine beta-casein below the isoelectric pH. J Agric Food Chem 2008;56:2192–2198.
- Dauphas S, Mouhous-Riou N, Metro B, et al. The supramolecular organisation of β-casein: effect on interfacial properties. Food Hydrocolloids 2005;19:387–393.
- Mikheeva LM, Grinberg NV, Grinberg VY, et al. Thermodynamics of micellization of bovine β-casein studied by high-sensitivity differential scanning calorimetry. Langmuir 2003;19:2913–2921.
- Sahin NO, Arslan H. Inclusion complex of prednisolone with skimmed milk. Part I: physicochemical characterization. Yakugaku Zasshi 2007;127:1255–1261.
- Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 2004;93:563–570.
- Sinha S, Ali M, Baboota S, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 2010;11:518–527.
- Anton Girones M, Roan Roan J, de la Hoz B, Sanchez Cano M. Immediate allergic reactions by polyethylene glycol 4000: two cases. Allergol Immunopathol (Madr) 2008;36:110–112.
- Shelanski HA. PVP K-30 14C single dose excretion study – unpublished report from the Industrial Toxicology Laboratories United States of America. Submitted to the World Health Organization by BASF; 1953.
- Shelanski HA. Final two-year report of a chronic oral toxicity study with PVP (K-30) in rats. Unpublished report from the Industrial Biological Research and Testing Laboratories, United States of America. Submitted to the World Health Organization by BASF; 1957.
- Choudhary A, Rana AC, Aggarwal G, et al. Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B 2012;2:421–428.
- Sonar PA, Behera AL, Banerjee SK, et al. Preparation and characterization of Simvastatin solid dispersion using skimmed milk. Drug Dev Ind Pharm 2015;41:22–27.
- Topaloğlu Y, Yener G, Gönüllü Ü. Inclusion of ketoprofen with skimmed milk by freeze-drying. Il Farmaco 1999;54:648–652.
- Sze A, Erickson D, Ren L, Li D. Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow. J Colloid Interface Sci 2003;261:402–410.
- Saoji S, Atram S, Dhore P, et al. Influence of the component excipients on the quality and functionality of a transdermal film formulation. AAPS PharmSciTech 2015;16:1344–1356.
- Gupta P, Kakumanu V, Bansal A. Stability and solubility of Celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res 2004;21:1762–1769.
- Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 2010;12:263–271.
- Anderson NH, Bauer M, Boussac N, et al. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm Biomed Anal 1998;17:811–822.
- Sekar V, Kestens D, Spinosa-Guzman S, et al. The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers. J Clin Pharmacol 2007;47:479–484.
- Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J 2010;12:397–406.
- Dixit P, Jain DK, Dumbwani J. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J Pharmacol Toxicol Methods 2012;65:13–17.
- Bouma M, Nuijen B, Sava G, et al. Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-A. Int J Pharm 2002;248:247–259.
- Sudhakar B, Krishna M, Murthy K. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies. Appl Nanosci 2016;43–60.
- Morissette SL, Soukasene S, Levinson D, et al. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc Natl Acad Sci USA 2003;100:2180–2184.
- Rarokar NR, Saoji SD, Raut NA, et al. Nanostructured cubosomes in a thermoresponsive depot system: an alternative approach for the controlled delivery of docetaxel. AAPS PharmSciTech 2016;17:436–436.
- LeFevre ME, Olivo R, Vanderhoff JW, Joel DD. Accumulation of latex in Peyer's patches and its subsequent appearance in villi and mesenteric lymph nodes. Proc Soc Exp Biol Med 1978;159:298–302.
- Savić R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003;300:615–618.
- Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm 1998;168:221–229.
- Vo CL-N, Park C, Lee B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm 2013;85:799–813.
- Pandya R, Mehta T, Gohel M. Amalgamation of solid dispersion and adsorption technique. J Therm Anal Calorim 2015;120:699–709.
- Vijaya Kumar SG, Mishra DN. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi 2006;126:93–97.
- Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci 1969;58:538–549.
- Patel BB, Patel JK, Chakraborty S. Solubility enhancement using poly(meth)acrylate based solid dispersions. Powder Technol 2015;270:27–38.
- Patel M, Tekade A, Gattani S, Surana S. Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS PharmSciTech 2008;9:1262–1269.
- Zecevic DE, Meier R, Daniels R, Wagner K-G. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL-mixtures. Eur J Pharm Biopharm 2014;87:264–270.
- Diker B, Janneh O, van Heeswijk RP, Copeland KF. Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. Drug Metab Lett 2010;4:241–245.